Clinical Trial Update: Assessment of Patient Use of a New Device: RebiSmart

View source ↗

Summary

A completed clinical trial evaluating the use of the RebiSmart device in patients with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• RebiSmart

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Status: COMPLETED